Financial news on July 14, 2007

Business and Financial news
A Disease Affecting White Blood Cells, the Body’s Infection Fighters

Non-Hodgkin’s lymphoma, which typically strikes people in their 50s and 60s, occurs when white blood cells become cancerous. Read more..

By ALEX BERENSON - The New York Times

A Verdict, a Deal and an Online Masquerade Exposed

Conrad Black was found guilty while stocks soared, Alcan agreed to a buyout, and Whole Foods’ C.E.O. was revealed to have posted online under a pseudonym. Read more..

By JEREMY W. PETERS - The New York Times

Clinton Backs Higher Taxes for Investment Firm Managers

Senator Hillary Rodham Clinton became the latest Democratic presidential candidate to call for ending a “glaring inequity” in tax policy that favors investment managers. Read more..

By STEPHEN LABATON - The New York Times

G.E. Earnings Are Up 12%; Stock Buyback Is Increased

General Electric said commercial loans and major equipment sales contributed to the rise, and it confirmed the sale of its subprime mortgage unit. Read more..

By CLAUDIA H. DEUTSCH - The New York Times

Intel, in Shift, Joins Project on Education

Intel said it would join the board of the One Laptop Per Child Foundation, which seeks to build inexpensive computers for the developing world. Read more..

By JOHN MARKOFF - The New York Times

Justifying $5 Smoothies: It’s the Juice

Paul E. Clayton, C.E.O. of Jamba, parent company of Jamba Juice, the fruit smoothies retailer, talks about his company’s expansion and service. Read more..

By JUSTON JONES - The New York Times

Maker of Narcolepsy Drug Pleads Guilty in U.S. Case

Jazz Pharmaceuticals, maker of Xyrem, said it had improperly promoted the drug for unapproved uses. The company will pay $20 million in fines. Read more..

By ALEX BERENSON - The New York Times

Maker Settles Suit on Device for Hearts

Boston Scientific agreed to pay $195 million to settle claims related to a potentially flawed defibrillator made by its subsidiary, Guidant. Read more..

By BARRY MEIER - The New York Times

Pricing Pills by the Results

Drug makers are exploring the possibility of tying pharmaceutical prices to performance. Read more..

By ANDREW POLLACK - The New York Times

Vacation Is No Time to Be Idle

A growing number of people are taking “virtuous vacations” where they spend time working for nonprofit groups. Read more..

By PAUL B. BROWN - The New York Times

See what else happened on July 14, 2007